
Russia Declares Cancer Vaccine ‘Enteromix’ Ready for Clinical Use; To Be Provided Free for Patients
September 10, 2025
Russia has announced that its personalised cancer vaccine, Enteromix, developed using advanced mRNA technology, is now ready for clinical application following successful early trials. The vaccine, created by the National Medical Research Radiology Centre in collaboration with the Engelhardt Institute








